drugset / Press release
Positive Phase 1 Results of AKCEA-TTR-LRx Presented at the Heart Failure Society of America Annual Meeting
2019-09-16 · Ionis Pharmaceuticals · original ionis.com ↗
Data show >90% knockdown of TTR following administration in healthy volunteers
The release as fetched from its publisher. ionis.com ↗